Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results
Articolo
Data di Pubblicazione:
2022
Abstract:
SERENE UC (Study of a Novel Approach to Induction and Maintenance Dosing With Adalimumab in Patients With Moderate to Severe Ulcerative Colitis) evaluated the efficacy of higher adalimumab induction and maintenance dose regimens in patients with ulcerative colitis.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adalimumab; Clinical Trial Result; Inflammatory Bowel Disease; Moderately to Severely Active Ulcerative Colitis; Monoclonal Antibody
Elenco autori:
Panés, Julián; Colombel, Jean-Frederic; D'Haens, Geert R; Schreiber, Stefan; Panaccione, Remo; Peyrin-Biroulet, Laurent; Loftus, Edward V; Danese, Silvio; Tanida, Satoshi; Okuyama, Yusuke; Louis, Edouard; Armuzzi, Alessandro; Ferrante, Marc; Vogelsang, Harald; Hibi, Toshifumi; Watanabe, Mamoru; Lefebvre, Jessica; Finney-Hayward, Tricia; Sanchez Gonzalez, Yuri; Doan, Thao T; Mostafa, Nael M; Ikeda, Kimitoshi; Xie, Wangang; Huang, Bidan; Petersson, Joel; Kalabic, Jasmina; Robinson, Anne M; Sandborn, William J
Link alla scheda completa:
Link al Full Text:
Pubblicato in: